Pharmaceutical Technology Competitors

Informa champions specialists working in academic and business-to-business markets, connecting people with knowledge to help them learn more, know more and do more. We’re a leading international events, digital services and academic knowledge business, headquartered in the UK and a member of the UK’s FTSE 100 group of public companies. We’re also home to a fantastic, inclusive community of over 14,000 colleagues across 30 countries, and a place where our colleagues have the freedom and flexibility to bring ideas to life, do work that makes a real impact and discover opportunities to grow. Our businesses include Informa Markets, Informa TechTarget, Informa Connect, Informa Festivals and Taylor & Francis, but if you work in one of the specialist markets we serve, you might also know us through our brands. In Pharma, Medical and Biotech, that includes WHX Dubai, CPHI and EBD; in Tech, Enterprise Connect, AI Summit, Black Hat and GDC; in Natural Products, New Hope Network, Vitafoods and Natural Products Expo; in Beauty & Aesthetics, China Beauty Expo and Premier Beauty; in Finance, SuperReturn International, Money20/20, Finovate and IGM; in Research and Advanced Learning, Routledge and F1000; and many more brands in more markets too.

Springer Nature publishes journals, databases and online products and services across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 70 journals are published, some in association with prestigious academic societies. Nature Portfolio provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs. Nature was first published in 1869. Springer Nature has its principal offices in London, New York and Tokyo with offices in offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC.

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments. PhRMA is committed to working with stakeholders in Washington, across the country and around the world to: 🔹Expand patient access to safe and effective medicines through a free market, without price controls 🔹Protect strong intellectual property incentives 🔹Promote transparent, effective regulation and a free flow of information to patients We’re building a policy environment where science can thrive, patients can benefit and cures can exist.